淋巴瘤
霍奇金淋巴瘤
医学
非霍奇金淋巴瘤
肿瘤科
内科学
免疫学
作者
Jamés O. Armitage,Randy D. Gascoyne,Matthew A. Lunning,Franco Cavalli
出处
期刊:The Lancet
[Elsevier BV]
日期:2017-01-31
卷期号:390 (10091): 298-310
被引量:1070
标识
DOI:10.1016/s0140-6736(16)32407-2
摘要
Lymphomas can affect any organ in the body, present with a wide range of symptoms, and be seen by primary care physicians and physicians from most specialties. They are traditionally divided into Hodgkin's lymphoma (which accounts for about 10% of all lymphomas) and non-Hodgkin lymphoma, which is the topic of this Seminar. Non-Hodgkin lymphoma represents a wide spectrum of illnesses that vary from the most indolent to the most aggressive malignancies. They arise from lymphocytes that are at various stages of development, and the characteristics of the specific lymphoma subtype reflect those of the cell from which they originated. Since this topic was last reviewed in The Lancet in 2012, advances in understanding the biology and genetics of non-Hodgkin lymphoma and the availability of new diagnostic methods and therapies have improved our ability to manage patients with this disorder.
科研通智能强力驱动
Strongly Powered by AbleSci AI